CCM
RLYB icon

CAAS Capital Management’s Rallybio RLYB Stock Holding History

CAAS Capital Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,934
Closed -$178K – 778
2023
Q2 		$178K Sell
3,934
-16,607
-81% -$814K 0.01% 543
2023
Q1 		$938K Sell
20,541
-12,177
-37% -$629K 0.05% 296
2022
Q4 		$1.72M Buy
+32,718
New +$1.93M 0.1% 214
2021
Q4 		– Sell
-1,250
Closed -$176K – 1015
2021
Q3 		$176K Buy
+1,250
New +$147K ﹤0.01% 746

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAAS Capital Management's RLYB Position: Q3 2023 in Review

CAAS Capital Management sold out of Rallybio (RLYB) in Q3 2023, closing a stake of 3,934 shares — an estimated $178K sold.

CAAS Capital Management first reported a position in RLYB in Q3 2021 and held it in 4 quarters. The position peaked at $1.72M in Q4 2022. 58 funds tracked by Wall St. Rank hold RLYB as of Q3 2023.

  • CAAS Capital Management reported no remaining Rallybio position as of Q3 2023 after selling out during the quarter.
  • CAAS Capital Management sold 3,934 Rallybio shares in Q3 2023, an estimated $178K.
  • CAAS Capital Management first reported a position in Rallybio in Q3 2021 and held it in 4 quarters.
  • CAAS Capital Management's Rallybio position peaked at $1.72M in Q4 2022.
  • 58 funds tracked by Wall St. Rank held Rallybio as of Q3 2023.

Based on CAAS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.